NASDAQ:PDSB
PDS Biotechnology Corporation
- Stock
Last Close
3.94
26/07 20:00
Market Cap
129.11M
Beta: 1.87
Volume Today
141.71K
Avg: 364.73K
PE Ratio
−3.04
PFCF: −5.01
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -6.88M - | -12.20M 77.27% | -28.08M 130.13% | -38.82M 38.26% | -50.86M 31.01% | -40.87M 19.65% | -7.00M 82.88% | -14.85M 112.15% | -16.92M 13.95% | -40.85M 141.48% | -42.94M 5.11% | |
depreciation and amortization | 4.44K - | 31.23K 602.72% | 53.12K 70.09% | 100.12K 88.49% | 182.92K 82.70% | 174.35K 4.69% | 98.41K 43.55% | 15.61K 84.14% | 5.36K 65.68% | 86 98.39% | 57.33K 66,558.14% | |
deferred income tax | 35.29K - | 198.96K 463.81% | 268.80K 35.10% | 141.28K 47.44% | 2.82M 1,897.92% | -381.51K 113.52% | ||||||
stock based compensation | 260.36K - | 1.30M 398.53% | 2.90M 123.37% | 5.31M 82.98% | 6.40M 20.65% | 7.61M 18.97% | 3.18M 58.29% | 452.29K 85.76% | 4.11M 808.76% | 5.20M 26.42% | ||
change in working capital | -2.28M - | 1.70M 174.43% | 1.26M 26.00% | 782.43K 37.72% | 3.07M 292.94% | -3.43M 211.51% | -4.60M 34.30% | 1.07M 123.23% | 75.82K 92.91% | 4.47M 5,802.27% | -199.28K 104.45% | |
accounts receivables | ||||||||||||
inventory | ||||||||||||
accounts payables | -1.66M - | 526.87K 131.71% | -71.75K 113.62% | 1.42M 2,079.84% | 898.10K 36.78% | -3.97M 542.01% | -1.98M 50.18% | 217.50K 111.00% | -105.82K 148.65% | -90.12K 14.84% | 5.76M 6,495.69% | |
other working capital | -619.53K - | 1.17M 288.98% | 1.33M 13.43% | -638.12K 148.05% | 2.18M 441.06% | 541.19K 75.13% | -2.63M 585.39% | 852.16K 132.44% | 181.64K 78.68% | 4.57M 2,413.28% | -5.96M 230.62% | |
other non cash items | 854.34K - | -575.98K 167.42% | 1.92M 433.06% | 175.91K 90.83% | 363.91K 106.87% | 531.67K 46.10% | -9.36M 1,861.11% | 160.68K 101.72% | 241.03K 50.00% | 5.47M 2,171.05% | 9.45M 72.60% | |
net cash provided by operating activities | -8.04M - | -9.72M 20.76% | -21.75M 123.90% | -32.19M 47.98% | -40.70M 26.43% | -33.15M 18.54% | -18.07M 45.49% | -13.15M 27.25% | -12.49M 5.04% | -25.71M 105.91% | -33.64M 30.83% | |
investments in property plant and equipment | -136.89K - | -884.79K 546.33% | -1.31M 47.50% | -686.71K 47.38% | -188.72K 72.52% | |||||||
acquisitions net | 29.11M - | |||||||||||
purchases of investments | ||||||||||||
sales maturities of investments | ||||||||||||
other investing activites | 275K - | |||||||||||
net cash used for investing activites | -136.89K - | -884.79K 546.33% | -1.31M 47.50% | -686.71K 47.38% | -188.72K 72.52% | 29.38M - | ||||||
debt repayment | -22.05K - | -533.73K - | -1.49M 178.90% | -20.99M - | -449.33K - | -59.30K 86.80% | ||||||
common stock issued | 86.06M - | 17.38M - | 750K - | 29.76M 3,867.53% | 48.54M 63.14% | 9.86M 79.70% | 16.44M 66.76% | |||||
common stock repurchased | -270.96 - | |||||||||||
dividends paid | -270.96 - | |||||||||||
other financing activites | 15.92M - | 16.47M 3.45% | 53.99M 227.81% | 10.57M 80.42% | 5.17M 51.09% | 721.20K 86.05% | 750 99.90% | 70.46K 9,294.53% | 344.13K 388.40% | 24.88M 7,130.22% | ||
net cash used provided by financing activities | 15.90M - | 16.47M 3.60% | 139.52M 747.06% | 9.08M 93.49% | 22.55M 148.26% | -20.27M 189.87% | 750K 103.70% | 29.83M 3,876.93% | 48.89M 63.91% | 34.29M 29.87% | 16.38M 52.24% | |
effect of forex changes on cash | ||||||||||||
net change in cash | 7.72M - | 5.87M 23.93% | 116.46M 1,883.72% | -23.79M 120.43% | -18.33M 22.95% | -53.42M 191.43% | 12.06M 122.57% | 16.68M 38.31% | 36.40M 118.27% | 8.58M 76.44% | -17.26M 301.22% | |
cash at beginning of period | 140.93K - | 7.86M 5,475.82% | 13.73M 74.71% | 130.19M 848.28% | 106.40M 18.27% | 88.07M 17.23% | 103.69K 99.88% | 12.16M 11,628.38% | 28.84M 137.13% | 65.24M 126.23% | 73.82M 13.15% | |
cash at end of period | 7.86M - | 13.73M 74.71% | 130.19M 848.28% | 106.40M 18.27% | 88.07M 17.23% | 34.65M 60.66% | 12.16M 64.90% | 28.84M 137.13% | 65.24M 126.23% | 73.82M 13.15% | 56.56M 23.38% | |
operating cash flow | -8.04M - | -9.72M 20.76% | -21.75M 123.90% | -32.19M 47.98% | -40.70M 26.43% | -33.15M 18.54% | -18.07M 45.49% | -13.15M 27.25% | -12.49M 5.04% | -25.71M 105.91% | -33.64M 30.83% | |
capital expenditure | -136.89K - | -884.79K 546.33% | -1.31M 47.50% | -686.71K 47.38% | -188.72K 72.52% | |||||||
free cash flow | -8.18M - | -10.60M 29.56% | -23.06M 117.53% | -32.88M 42.58% | -40.89M 24.37% | -33.15M 18.91% | -18.07M 45.49% | -13.15M 27.25% | -12.49M 5.04% | -25.71M 105.91% | -33.64M 30.83% |
All numbers in USD (except ratios and percentages)